ISIN | CH0272292837 |
---|---|
Valor Number | 27229283 |
Bloomberg Global ID | |
Fund Name | JSS Sustainable Equity - Switzerland I CHF dist |
Fund Provider |
J. Safra Sarasin Investmentfonds AG
Basel, Switzerland Phone: +41 58 317 44 44 Web: www.jsafrasarasin.com |
Fund Provider | J. Safra Sarasin Investmentfonds AG |
Representative in Switzerland | |
Distributor(s) |
Bank J. Safra Sarasin AG Basel Phone: +41 58 317 44 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | The fund seeks long-term capital growth. It invests primarily in investment rights in Swiss securities of companies that contribute to a sustainable economic approach and other investments permitted under the Fund Agreement. These companies are distinguished by environmentally friendly, ecologically efficient management and for whom a proactive approach to relationships to the key stakeholders (e.g. employees, customers, donors, shareholders, the public authorities) is an important component of strategy. As a result, the Fund invests in the industry leaders who are utilizing the concept of sustainable development as a strategic opportunity. Individual industries may be excluded. Up to 20% of fund assets may be invested in bonds denominated in Swiss Francs (CHF). Furthermore, the Fund may also hold liquid assets in Swiss Francs (CHF). |
Peculiarities |
Current Price * | 106.27 CHF | 31.03.2025 |
---|---|---|
Previous Price * | 108.33 CHF | 28.03.2025 |
52 Week High * | 110.81 CHF | 03.03.2025 |
52 Week Low * | 97.86 CHF | 20.12.2024 |
NAV * | 106.27 CHF | 31.03.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 127,707,483 | |
Unit/Share Assets *** | 18,071,612 | |
Trading Information SIX |
YTD Performance | +6.73% |
30.12.2024 - 31.03.2025
30.12.2024 31.03.2025 |
---|---|---|
1 month | -2.79% |
28.02.2025 - 31.03.2025
28.02.2025 31.03.2025 |
3 months | +6.24% |
03.01.2025 - 31.03.2025
03.01.2025 31.03.2025 |
6 months | -0.54% |
30.09.2024 - 31.03.2025
30.09.2024 31.03.2025 |
1 year | +2.82% |
02.04.2024 - 31.03.2025
02.04.2024 31.03.2025 |
2 years | +5.17% |
31.03.2023 - 31.03.2025
31.03.2023 31.03.2025 |
3 years | -0.22% |
31.03.2022 - 31.03.2025
31.03.2022 31.03.2025 |
5 years | +15.16% |
08.01.2021 - 31.03.2025
08.01.2021 31.03.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 13.47% | |
---|---|---|
Nestle SA | 12.79% | |
Novartis AG Registered Shares | 10.70% | |
UBS Group AG | 7.74% | |
Zurich Insurance Group AG | 6.94% | |
ABB Ltd | 6.00% | |
Lonza Group Ltd | 4.49% | |
Sika AG | 4.08% | |
Partners Group Holding AG | 3.74% | |
Compagnie Financiere Richemont SA Class A | 2.75% | |
Last data update | 31.12.2024 |
TER | 0.74% |
---|---|
TER date | 30.08.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.90% |
Ongoing Charges *** | 0.72% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |